Clinical Trial Associate I
A Clinical Trial Associate I provides administrative support to clinical study teams in Madrid. The role involves managing eTMF documentation, site files, and clinical trial supplies.
The English-language job board for Spain
A Clinical Trial Associate I provides administrative support to clinical study teams in Madrid. The role involves managing eTMF documentation, site files, and clinical trial supplies.
You will lead the strategic vision, operations, and financial health of the Quality organization.
A Start-Up Associate Contractor will coordinate local site start-up activities for clinical trials. The role involves regulatory submissions, document collection, and contract negotiation.
Allucent is a global provider of clinical development services for the biopharmaceutical industry, specializing in supporting small and mid-sized companies in bringing new drugs and therapies to market. With a focus on oncology, rare diseases, and other complex therapeutic areas, Allucent offers a range of services including clinical trial management, regulatory affairs, and data management. The company operates globally with a significant presence in the United States and Europe, employing a team of experienced professionals dedicated to advancing medical innovation.
In Spain, Allucent is expanding its clinical operations, offering opportunities for experienced professionals like Clinical Project Managers and senior medical leadership. The company values a collaborative and science-driven culture, making it an attractive option for international experts in clinical research. With a global footprint and a focus on niche therapeutic areas, Allucent provides a dynamic environment for professionals looking to contribute to cutting-edge drug development while working from Spain.
Allucent was formed in 2019 through the merger of two established clinical research organizations, Theradex and PRA's early phase business, to create a dedicated provider of clinical development services for biopharmaceutical companies. The company has since expanded its global footprint, focusing on complex therapeutic areas and offering a full suite of services from early-phase to late-phase trials.